Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

  • Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    Vection Secures $7.3M Defence Extension as AI Demand Strengthens
    • News

  • Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology
    • News

  • Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    Harris Technology boosts retail margins in FY25 through growth of refurbished tech
    • News

  • Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.
    • News

  • dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    dorsaVi Powers Ahead with High-Speed RRAM for Smarter Wearables and Edge AI
    • News

  • Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    Nanoveu Secures $2 Million to Fast-Track Commercial Launch of ECS-DoT Chip and AIoT Platform
    • News

  • Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    Archer Unlocks Cryogenic Sensor Breakthrough for Quantum Computing
    • News

  • EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    EGL Secures $1.9M PFAS Plant Contract as Demand for Clean-Up Technologies Surges
    • News

Industry wide recall means rough seas for seafood producers

  • In News
  • November 22, 2021
  • Samantha Freidin
Industry wide recall means rough seas for seafood producers

The seafood industry is in damage control mode after authorities issued an industry wide recall on products from the Coffin Bay oyster production zone following a rise in cases of food poisoning from products grown in the region. 

The South Australian Department of Health and Wellbeing (DHW) and the Department of Primary Industries ordered all oyster production in the region to cease temporarily and issued the recall for products sold, consigned or distributed for salt from 4th September 2021 to 16th November 2021. Harvesting and sales must be halted for the foreseeable future until the issue is resolved. 

Vibrio Parahaemolyticus (VP) is the pesky bacteria responsible for the interruption. Commonly found in marine, coastal and tidal waters, the bacteria is often found in shellfish when harvested. From the same family as the bacterium that causes cholera, VP causes severe gastrointestinal illness in humans. 

SA Health deputy chief public health officer Chris Lease advised that there had been 56 Vibrio parahaemolyticus infections linked to eating raw oysters from the region; of those, three people have been hospitalised.

Dire as it may sound, the bacterium can be controlled with food safety controls such as harvesting practices, product sampling and maintenance of the cold chain post-harvest. 

Angel Seafood (ASX: AS1) is a producer of oysters in the Coffin Bay area and has had to cease harvesting for the time being. The Company continues to sell some oysters from other bays not in the region. The Company predicts that 2.6 million oysters were harvested and sold over the recall period, however, based on normal shelf life, these would have been consumed by now. The Company is not able to provide an estimate of the quantity of oysters subject to the recall as stock from earlier sales may have been frozen. 

Authorities will conduct thorough audits of all onsite oyster production handling practices from growers in the region, and the supply chain and logistics providers. This will help ensure that practices are up to code and further outbreaks do not occur. 

Angel has submitted a compliance plan for the upcoming audit and details of updated production and distribution practices once sales recommence. Angel’s oysters are traceable through every step of their supply chain, allowing for isolation and management of potential incidents. The Company did not indicate a predicted financial cost for the interruption. 

Production is expected to recommence on November 29th following the all clear from authorities provided compliance with health and safety protocols is met. 

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  •  
  •  
  •  
  •  
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Samantha Freidin
Samantha Freidin is a business journalist at Emerald Financial whilst also completing a Masters of Marketing and Digital Communications at Monash University.
Latest posts by Samantha Freidin (see all)
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial - September 1, 2022
  • How this company is developing medtech to support Indigenous community health - August 22, 2022
  • A round of ap-paws for PharmAust, changing the ruff prognosis for dogs with lymphoma - August 17, 2022
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.